Resource Center

Patents

Clinically Intelligent Diagnostic Devices and Methods

Issued Patents:
08/16/2011    US 7,998,679 (United States)        
11/24/2009    US 7,622,250                             
07/28/2009    US 7,566,533
06/14/2005    US 6,905,816
11/12/2008    JP 4179876 (Japan)
01/20/2010    EP 1397679 (Europe)

Published Applications:
12/22/2011    US 2011/0312531
06/30/2010    EP 2202520
02/17/2003    AU 3052302 (Australia)
05/30/2002    WO 2002/042775
05/30/2002    CA 2430110 (Canada)


Methods and Systems for Designing Primers and Probes

Published Applications:
11/08/2007    US 2007/0259337
06/07/2007    WO 2007/064758
08/27/2008    EP 1960555
06/07/2007    CA 2632380
06/07/2007    AU 2006320541
04/30/2009    JP 2009/517087


Optimized Probes and Primers and Methods of Using Same for the Detection, Quantitation, Isolation and Sequencing of Cytomegalovirus and Epstein-Barr Virus

Published Applications:
11/25/2010    US 2010/0297612
01/27/2011    WO 2010/135514

 

Optimized Probes and Primers and Method of Using Same for the Detection of Herpes Simplex Virus

Published Applications:
01/20/2011    US 2011/0014598
01/07/2010    WO 2009/089257
10/20/2010    EP 2240503


Optimized Probes and Primers and Methods of Using Same for the Detection and Quantification of BK Virus

Published Applications:
10/01/2009    US 2009/0246754
11/12/2009    WO 2009/137137
12/08/2010    EP 2257648


Optimized Probes and Primers and Methods of Using Same for the Detection, Quantification and Grouping of HIV-1

Published Applications:
10/15/2009    US 2009/0258342
12/30/2009    WO 2009/126517


Optimized Oligonucleotides and Methods of Using Same for the Detection, Isolation, Quantification, Monitoring and Sequencing of Bordetella

Published Applications:
12/20/2010    US 2010/0330573
03/10/2011    WO 2010/151771


Optimized Probes and Primers and Methods of Using Same for the Detection, Screening, Isolation and Sequencing of Vancomycin Resistance Genes and Vancomycin Resistant Enterococci

Published Applications:
08/18/2011    US 2011/0200995
09/29/2011    WO 2011/029034

Optimized Probes and Primers and Methods of Using Same for the Binding, Detection, Differentiation, Isolation and Sequencing of Influenza A; Influenza B; 2009 Influenza A/H1N1; and a 2009 Influenza A/H1N1 RNA Sequence Mutation Associated with Oseltamivir Resistance

Published Application:
10/13/2011    US 2011/0250583
06/03/2011    WO 2011/035322

Optimized Oligonucleotides and Methods of Using Same for the Detection, Isolation, Amplification, Quantification, Monitoring, Screening and Sequencing of Clostridium Difficile Genes Encoding Toxin B, and/or Toxin A and/or Binary Toxin

Published Application:
10/20/2011    US 2011/0256535
08/18/2011    WO 2011/100443 
 

Optimized Oligonucleotides and Methods of Using Same for the Screening, Detection, Isolation, Quantitation, Monitoring and Sequencing of Prostate Cancer Associated Viruses and Host Biomarkers

Published Application:
10/20/2011    US 2011/0256537
10/20/2011    WO 2011/130273

Optimized Probes and Primers and Methods of Using Same for the Detection, Screening, Isolating and Sequencing of MRSA, MSSA, Staphylococcus Markers, and the Antibiotic Resistance Gene MecA

Published Application:
12/15/2011    US 2011/0306510

Optical Determination of In Vivo Properties

Issued Patent:
05/29/2007    US 7,225,005